Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
4.708M
Cash
1.421M
Avg Qtr Burn
-1.776M
Short % of Float
5.40%
Insider Ownership
18.42%
Institutional Own.
2.52%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BCDA-02 CardiAMP cell therapy Details Heart failure, Myocardial ischemia | Phase 3 Data readout | |
BCDA-01 CardiAMP cell therapy Details Ischemic stroke, Heart failure | Phase 3 Data readout | |
BCDA-03 CardiALLO cell therapy Details Ischemic stroke, Heart failure | Phase 1/2 Data readout |